Philippines FDA Slashes Generic Approval Timelines
Cuts Review From 120 To 45 Days As President Urges Lower Prices ‘Similar To India’
The Philippines Food and Drug Administration is set to shorten the timeline for generic review and approval from 120 days to just 45 days, as part of efforts to register new generics and bring down prices.
